|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100053787 |
|
最近更新日期: Date of Last Refreshed on: |
2021-11-29 03:22:46 |
|
注册时间: Date of Registration: |
2021-11-29 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
儿童肾小球基底及基底膜变薄标准研究膜厚度 |
|
Public title: |
study on thickness of glomerular basement membrane with children and thinning basement membrane nephropathy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
儿童肾小球基底及基底膜变薄标准研究膜厚度 |
|
Scientific title: |
study on thickness of glomerular basement membrane with children and thinning basement membrane nephropathy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
吴滢 |
研究负责人: |
吴滢 |
|
Applicant: |
wuying |
Study leader: |
wuying |
|
申请注册联系人电话: Applicant telephone: |
18917128031 |
研究负责人电话:
Study leader's |
18917128031 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wuy@shchildren.com.cn |
研究负责人电子邮件: Study leader's E-mail: |
wuy@shchildren.com.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市普陀区泸定路355号 |
研究负责人通讯地址: |
上海市普陀区泸定路355号 |
|
Applicant address: |
No.355 Luding Road, Putuo District, Shanghai |
Study leader's address: |
no.355 Luding Road, Putuo District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市儿童医院 |
||
|
Applicant's institution: |
Children's hospital of Shanghai |
||
|
研究负责人所在单位: |
上海市儿童医院 |
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2019R082-E01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市儿童医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2019-12-27 00:00:00 | ||
|
伦理委员会联系人: |
奚益群 |
||
|
Contact Name of the ethic committee: |
Xi Yiqun |
||
|
伦理委员会联系地址: |
上海市普陀区泸定路355号(上海市儿童医院) |
||
|
Contact Address of the ethic committee: |
No.355 Luding Road, Putuo District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
021-52976581 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市儿童医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Children's hospital of Shanghai |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市普陀区泸定路355号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.355 Luding Road, Putuo District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市儿童医院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Children's hospital of Shanghai |
||||||||||||||||||||||
|
研究疾病: |
薄基底膜肾病 |
||||||||||||||||||||||
|
Target disease: |
Thin basement membrane nephropathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
析因分组(即根据危险因素或暴露因素分组) |
||||||||||||||||||||||
|
Study design: |
Factorial |
||||||||||||||||||||||
|
研究目的: |
通过筛选多中心十年肾活检资料中符合微小病变肾病综合征不伴血尿的1岁~12岁患儿电镜标本为研究对象,应用Motic Med 6.0数码医学图像分析系统测定肾小球基底膜(GBM)厚度,以每岁年龄为一年龄组分层进行统计不同年龄组之间的差异,以确立基底膜不同年龄段的划分并建立每一年龄段的基底膜正常参考值范围,进一步对每一年龄段再进行性别分组了解性别之间差异及相关GBM数值,从而建立不同性别、年龄段儿童肾小球基底膜(GBM)厚度的正常参考值范围,拟建议儿童薄基底膜肾病(TBMN)的GBM弥漫变薄的标准,并在临床应用中进行初步验证。 |
||||||||||||||||||||||
|
Objectives of Study: |
In this study, electronic microscope specimens of children aged 1-12 years old who were in line with nephrotic syndrome without hematuria were selected from multi-center 10-year renal biopsy data,and use Motic Med 6.0 digital medical image analysis system to measure the thickness of glomerular basement membrane (GBM) .To establish the division of basement membrane in different age groups,we take every 1 year old as an age group to statistically analyze the differences among different age groups ,and in order to establish the normal reference range of basement membrane in each age group, and further divide each age group into gender groups to learn gender differences and related GBM values, so as to establish the normal reference range of GBM thickness in children of different genders and ages. It is proposed to recommend GBM diffuse thinning criteria for children with thin basement membrane nephropathy (TBMN) and conduct preliminary validation in clinical application. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)、患者年龄在 1~12岁之间; |
||||||||||||||||||||||
|
Inclusion criteria |
(1)The age of patient is between 1 to 12 years old; |
||||||||||||||||||||||
|
排除标准: |
电镜照片质量差,无法满足图像软件对测量的要求,再重新切片、摄片后仍不能测量者 |
||||||||||||||||||||||
|
Exclusion criteria: |
The electron microscope photos are unqualified and cannot meet the requirements of the imaging software, and the measurement still cannot be performed after re-slicing and filming. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-12-01 00:00:00至 To 2022-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-12-01 00:00:00 至 To 2022-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不涉及 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not involved |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验结束的6个月内,采用中国临床试验注册中心公共管理平台及时公开原始数据和研究计划书。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The raw data will be delivered through Clinical Trial Management Public Platform (ResMan) within 6 months after the end of the trial. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
在 2021年 12月 1 日到 2022年06月 30 日期间,从我院所接收的肾活检标本中按照规定的入排标准筛选合适病例,初步以每一岁为一个年龄段,根据文献查阅,收集样本110,最少不能低于20例,故设定每个年龄段至少20例。先从负责单位单中心测量数据绘制散点图,初步分析年龄趋势,再从其他合作中心补充,以年龄段分组,方差分析组间差异后再统计不同年龄段组之间的差异,建立基底膜不同年龄段的划分并建立每一年龄段的基底膜正常参考值范围 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
First,drawing scatterplot by measurement data from the responsible unit single center , analyze the trend of age preliminarily, as well as other cooperation centers' supplement by age group ,analyze the variance after the statistical difference between different age groups , so as to establish the division of basement membrane in different age groups,and establish the normal reference range of basement membrane in each age group |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |